ADC Therapeutics (NYSE:ADCT) reported its Q4 earnings results on Thursday, March 3, 2022 at 07:00 AM.
Here’s what investors need to know about the announcement.
Earnings
ADC Therapeutics beat estimated earnings by 54.65%, reporting an EPS of $-0.39 versus an estimate of $-0.86.
Revenue was up $17.01 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.33 which was followed by a 3.32% increase in the share price the next day.
Here’s a look at ADC Therapeutics’s past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | -0.92 | -0.82 | -0.90 | -0.38 |
| EPS Actual | -0.59 | -0.70 | -0.74 | -0.82 |
| Revenue Estimate | 7.39M | 2.37M | 90.00K | 860.00K |
| Revenue Actual | 13.15M | 3.76M | 0 | 0 |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.